Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy as a disease modifier.

James G Martin1, Karim Shalaby, Marie-Claire Michoud

  • 1Meakins Christie Laboratories, McGill University, Montreal, Quebec, Canada. james.martin@mcgill.ca

Paediatric Respiratory Reviews
|June 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial.

Cytotherapy·2026
Same author

Leukotriene C4 Synthase Deficiency Causes Spontaneous Emphysema in Female Mice.

American journal of respiratory cell and molecular biology·2025
Same author

IL-33 Induces a Protective Response against Irritant-induced Airway Inflammation and Dysfunction.

American journal of respiratory cell and molecular biology·2025
Same author

Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection.

Mucosal immunology·2025
Same author

Pregnancy enhances antiviral immunity independent of type I IFN but dependent on IL-17-producing γδ<sup>+</sup> T cells in the nasal mucosa.

Science advances·2024
Same author

T cell and airway smooth muscle interaction: a key driver of asthmatic airway inflammation and remodeling.

American journal of physiology. Lung cellular and molecular physiology·2024

Allergy treatments, known as immunotherapy, are evolving. New approaches aim to rebalance immune responses, shifting from excessive Th2 to beneficial Th1 activity, offering new hope for allergic disease management.

Area of Science:

  • Immunology
  • Allergy Research
  • Immune System Modulation

Background:

  • Traditional immunotherapy for allergic disease involves allergen exposure.
  • The hygiene hypothesis suggests environmental changes impair normal immune development, leading to Th2-dominant responses.
  • This necessitates therapies promoting a shift from Th2 to Th1 immune responses.

Purpose of the Study:

  • To explore emerging immunotherapies for allergic diseases.
  • To investigate novel strategies for immune modulation based on T cell function.
  • To examine therapies aimed at correcting Th2-type immune skewing.

Main Methods:

  • Review of traditional desensitization immunotherapy.
  • Analysis of novel immune modulation approaches including bacterial vaccines.

Related Experiment Videos

  • Exploration of Toll-like receptor ligands and CpG motifs for immune stimulation.
  • Assessment of anti-IgE therapy efficacy.

    • Main Results:

    • Emerging immunotherapies offer new avenues beyond traditional allergen exposure.
    • Therapies stimulating Th1 responses show promise in managing allergic conditions.
    • Anti-IgE therapy has demonstrated success in treating allergic diseases.

    Conclusions:

    • Immunotherapy for allergic diseases is advancing with new immune-modulating strategies.
    • Targeting T cell responses and promoting a Th1 shift are key therapeutic goals.
    • Novel approaches like TLR ligands, CpG motifs, and anti-IgE offer effective alternatives and adjuncts to traditional immunotherapy.